Sharing together the new treatment approach of Chronic Weight Management and Type 2 Diabetes by discussing Phase lll SURMOUNT and SURPASS trial programs of the first and only GLP-1/GIP receptor agonist, along with clinical cases and clinical practice from our local experts.
1- Explore how to use Mounjaro to help your patients with T2D and Weight Management achieve their treatment goals. 2- Start and continue With Confidence with Mounjaro Kwikpen

FREE
Free
26 Aug 2024 To 26 Aug 2024
09:00 PM To 10:30 PM
Certificate Available
Online Click Here